Mitzner S - Search Results

1

Uncertainty in the impact of liver support systems in acute-on-chronic liver failure: a systematic review and network meta-analysis.

Ocskay K, Kanjo A, Gede N, Szakács Z, Pár G, Erőss B, Stange J, Mitzner S, Hegyi P, Molnár Z. Ocskay K, et al. Among authors: mitzner s. Ann Intensive Care. 2021 Jan 18;11(1):10. doi: 10.1186/s13613-020-00795-0. Ann Intensive Care. 2021. PMID: 33462764 Free PMC article. Review.

2

Dialysis against a recycled albumin solution enables the removal of albumin-bound toxins.

Stange J, Ramlow W, Mitzner S, Schmidt R, Klinkmann H. Stange J, et al. Among authors: mitzner s. Artif Organs. 1993 Sep;17(9):809-13. doi: 10.1111/j.1525-1594.1993.tb00635.x. Artif Organs. 1993. PMID: 8240075

3

Primary or established liver cells for a hybrid liver? Comparison of metabolic features.

Stange J, Mitzner S, Strauss M, Fischer U, Lindemann S, Peters E, Holtz M, Drewelow B, Schmidt R. Stange J, et al. Among authors: mitzner s. ASAIO J. 1995 Jul-Sep;41(3):M310-5. doi: 10.1097/00002480-199507000-00020. ASAIO J. 1995. PMID: 8573814

4

Increased soluble CD14 levels in patients on hemodialysis. Influence of dialysate endotoxin or incompatibility to dialyzer membranes?

Mitzner S, Stange J, Pichel K, Handschuk I, Korten G, Ehlers M, Schutt C, Schmidt R. Mitzner S, et al. ASAIO J. 1995 Jul-Sep;41(3):M707-8. ASAIO J. 1995. PMID: 8573897 No abstract available.

5

Cell sources for bioartificial liver support.

Stange J, Mitzner S. Stange J, et al. Among authors: mitzner s. Int J Artif Organs. 1996 Jan;19(1):14-7. Int J Artif Organs. 1996. PMID: 8641814 Review.

6

Hepatocyte encapsulation--initial intentions and new aspects for its use in bioartificial liver support.

Stange J, Mitzner S. Stange J, et al. Among authors: mitzner s. Int J Artif Organs. 1996 Jan;19(1):45-8. Int J Artif Organs. 1996. PMID: 8641818 Review. No abstract available.

7

Role of transport proteins in bioartificial liver assist systems.

Mitzner S, Stange J, Freytag J, Lindemann S, Schmidt R. Mitzner S, et al. Int J Artif Organs. 1996 Jan;19(1):49-52. Int J Artif Organs. 1996. PMID: 8641819 Review. No abstract available.

8

A carrier-mediated transport of toxins in a hybrid membrane. Safety barrier between a patients blood and a bioartificial liver.

Stange J, Mitzner S. Stange J, et al. Among authors: mitzner s. Int J Artif Organs. 1996 Nov;19(11):677-91. Int J Artif Organs. 1996. PMID: 8970836

9

Targeted chemotherapy by intratumour injection of encapsulated cells engineered to produce CYP2B1, an ifosfamide activating cytochrome P450.

Löhr M, Müller P, Karle P, Stange J, Mitzner S, Jesnowski R, Nizze H, Nebe B, Liebe S, Salmons B, Günzburg WH. Löhr M, et al. Among authors: mitzner s. Gene Ther. 1998 Aug;5(8):1070-8. doi: 10.1038/sj.gt.3300671. Gene Ther. 1998. PMID: 10326030

10

Liver support by extracorporeal blood purification: a clinical observation.

Stange J, Mitzner SR, Klammt S, Freytag J, Peszynski P, Loock J, Hickstein H, Korten G, Schmidt R, Hentschel J, Schulz M, Löhr M, Liebe S, Schareck W, Hopt UT. Stange J, et al. Among authors: mitzner sr. Liver Transpl. 2000 Sep;6(5):603-13. doi: 10.1053/jlts.2000.7576. Liver Transpl. 2000. PMID: 10980060 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

119 results

Search Page

Filters